Terazosin Impurity (CAS 60548-08-5) — formula C14H21Cl2N5O2, molecular weight 362.3; category pharmaceutical intermediates and APIs.
Terazosin Impurity (CAS 60548-08-5) is a chemical raw material in the pharmaceutical intermediates and APIs category. Its molecular formula C14H21Cl2N5O2 comprises 14 C, 21 H, 2 Cl, 5 N, 2 O atoms. Its molecular weight is about 362.3. As a sourcing and distribution partner we help locate and compare this item across domestic and cross-border channels, arranging samples and batch orders with full COA and compliance files.
| CAS Number | 60548-08-5 |
|---|---|
| Molecular Formula | C14H21Cl2N5O2 |
| Molecular Weight | 362.3 |
| Category | Pharmaceutical Intermediates & APIs |
Terazosin Impurity is a pharmaceutical intermediate or API compound with CAS registry number 60548-08-5 and molecular formula C14H21Cl2N5O2 (molecular weight 362.3), belonging to the pharmaceutical intermediates and APIs segment of chemical raw materials.
CAS number: 60548-08-5
Its molecular formula C14H21Cl2N5O2 comprises 14 C, 21 H, 2 Cl, 5 N, 2 O atoms.
Also known as: Terazosin Impurity · 1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)哌嗪二盐酸盐
Category: pharmaceutical intermediates and APIs
The CAS registry number of Terazosin Impurity is 60548-08-5.
Molecular formula C14H21Cl2N5O2, molecular weight 362.3.
It is also registered under: Terazosin Impurity, 1-(4-氨基-6,7-二甲氧基-2-喹唑啉基)哌嗪二盐酸盐.
Category: Pharmaceutical Intermediates & APIs.
Packaging is agreed per order, from lab-scale packs to bulk, and confirmed with each order rather than fixed on the page. A Certificate of Analysis (COA) ships with every batch and MSDS is available; where the end use carries a regulatory limit (food contact, pharmaceutical or cosmetic), state the standard at enquiry and the grade is set against it.
Independent reference data for Terazosin Impurity (CAS 60548-08-5), compiled from public chemistry databases.
| CAS Number | 60548-08-5 |
|---|---|
| PubChem CID | 71587207 |
| Molecular Formula | C14H21Cl2N5O2 |
| IUPAC Name | 6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine;dihydrochloride |
| UNII (FDA) | 5GN8I6ZYXY |
| Molecular Weight | 362.3 |
|---|---|
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 361.1072303 |
| Monoisotopic Mass | 361.1072303 |
| Topological Polar Surface Area | 85.5 |
| Heavy Atom Count | 23 |
60548-08-5; 6,7-Dimethoxy-2-(piperazin-1-yl)quinazolin-4-amine dihydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)piperazine, dihydrochloride; UNII-5GN8I6ZYXY; 5GN8I6ZYXY; 4-Quinazolinamine, 6,7-dimethoxy-2-(1-piperazinyl)-, dihydrochloride; 2-(1-Piperazinyl)-4-amino-6,7-dimethoxyquinazoline-2HCl; 4-Quinazolinamine, 6,7-dimethoxy-2-(1-piperazinyl)-, hydrochloride (1:2); RefChem:196948; 886-571-4; 6,7-dimethoxy-2-piperazin-1-ylquinazolin-4-amine;dihydrochloride; N-Des((tetrahydrofuran-2-yl)methanone)) Terazosin Dihydrochloride; N-Des((tetrahydrofuran-2-yl)methanone))TerazosinDihydrochloride; Terazosin Impurity6; Terazosin-004-2HCl; Doxazosin EP Impurity G HCl
| Notified hazard statements | H315 (100%), H319 (100%), H335 (100%) |
|---|
Source: PubChem / Wikidata; the batch COA governs where values differ.
Supplier: Jinan Shenghe Chemical Co., Ltd.